Avita Medical (RCEL) Competitors $4.30 +0.01 (+0.12%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCEL vs. SMLR, CBLL, BFLY, DCTH, RXST, SNWV, NPCE, SMTI, CLPT, and TCMDShould you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Delcath Systems (DCTH), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Sanara MedTech (SMTI), ClearPoint Neuro (CLPT), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Avita Medical vs. Its Competitors Semler Scientific CeriBell Butterfly Network Delcath Systems RxSight Sanuwave Health NeuroPace Sanara MedTech ClearPoint Neuro Tactile Systems Technology Avita Medical (NASDAQ:RCEL) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership. Do analysts rate RCEL or SMLR? Avita Medical presently has a consensus target price of $12.40, indicating a potential upside of 188.71%. Semler Scientific has a consensus target price of $81.75, indicating a potential upside of 179.44%. Given Avita Medical's higher possible upside, equities research analysts plainly believe Avita Medical is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avita Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Which has more risk and volatility, RCEL or SMLR? Avita Medical has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Does the media refer more to RCEL or SMLR? In the previous week, Semler Scientific had 14 more articles in the media than Avita Medical. MarketBeat recorded 19 mentions for Semler Scientific and 5 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.91 beat Semler Scientific's score of 0.53 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Semler Scientific 4 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, RCEL or SMLR? Semler Scientific has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvita Medical$64.25M1.78-$61.85M-$1.97-2.18Semler Scientific$56.29M7.70$40.90M$2.4312.04 Is RCEL or SMLR more profitable? Semler Scientific has a net margin of 86.20% compared to Avita Medical's net margin of -68.87%. Semler Scientific's return on equity of 43.84% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avita Medical-68.87% -632.62% -71.52% Semler Scientific 86.20%43.84%32.88% Do institutionals & insiders have more ownership in RCEL or SMLR? 27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 16.4% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummarySemler Scientific beats Avita Medical on 12 of the 16 factors compared between the two stocks. Get Avita Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAvita MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$114.33M$2.83B$5.76B$9.85BDividend YieldN/A48.51%6.66%4.48%P/E Ratio-2.1822.7382.2726.62Price / Sales1.78714.51534.88109.99Price / CashN/A26.3325.7028.92Price / Book-8.956.7710.816.59Net Income-$61.85M$32.94M$3.28B$265.93M7 Day Performance-5.19%0.87%0.23%-0.26%1 Month Performance-16.76%8.15%10.66%6.61%1 Year Performance-50.00%0.70%51.27%22.69% Avita Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAvita Medical2.289 of 5 stars$4.30+0.1%$12.40+188.7%-54.2%$114.33M$64.25M-2.18130SMLRSemler Scientific3.4629 of 5 stars$29.64-3.2%$81.75+175.8%+10.0%$438.81M$56.29M12.20120News CoveragePositive NewsCBLLCeriBell2.5553 of 5 stars$11.83-1.2%$32.14+171.7%N/A$433.73M$65.44M-3.96N/ABFLYButterfly Network3.1764 of 5 stars$1.62-0.9%$3.00+85.8%+40.8%$405.30M$82.06M-5.77460Positive NewsDCTHDelcath Systems3.1527 of 5 stars$11.02+1.3%$24.50+122.3%-0.9%$385.49M$37.21M220.4060Positive NewsRXSTRxSight2.2725 of 5 stars$9.04-1.2%$10.00+10.6%-84.6%$369.88M$139.93M-11.30220SNWVSanuwave Health2.3917 of 5 stars$41.64-1.9%$55.00+32.1%N/A$356.77M$32.63M-5.0540News CoverageAnalyst ForecastNPCENeuroPace3.8468 of 5 stars$9.15+0.4%$16.60+81.4%+15.4%$302.70M$79.91M-10.89170News CoveragePositive NewsSMTISanara MedTech2.0876 of 5 stars$33.66-0.2%$50.00+48.5%-3.5%$299.65M$86.67M-29.0260CLPTClearPoint Neuro2.0883 of 5 stars$10.49flat$19.67+87.5%-19.6%$298.20M$31.39M-12.95110Positive NewsTCMDTactile Systems Technology2.3293 of 5 stars$13.31+1.1%$13.50+1.4%-1.8%$296.71M$292.98M21.471,037News CoveragePositive News Related Companies and Tools Related Companies Semler Scientific Alternatives CeriBell Alternatives Butterfly Network Alternatives Delcath Systems Alternatives RxSight Alternatives Sanuwave Health Alternatives NeuroPace Alternatives Sanara MedTech Alternatives ClearPoint Neuro Alternatives Tactile Systems Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCEL) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
